Home
Tore Elling Ulvestad's picture

Tore Elling Ulvestad

Professor
  • E-mailElling.Ulvestad@uib.no
  • Visitor Address
    Haukeland universitetssykehus, Laboratoriebygget
  • Postal Address
    Postboks 7804
    5020 Bergen
Textbook
  • 2017. Influensa, kapittel 40 i Indremedisin II . Forlaget Vett & Viten AS.
Academic article
  • 2019. The bacterial aetiology of pleural empyema. A descriptive and comparative metagenomic study. Clinical Microbiology and Infection. 1-6.
  • 2019. Bacteria and fungi in acute cholecystitis. A prospective study comparing next generation sequencing to culture. Journal of Infection. 1-8.
  • 2018. Species Level Description of the Human Ileal Bacterial Microbiota. Scientific Reports. 1-9.
  • 2017. Increased infiltration and tolerised antigen-specific CD8+ TEM cells in tumor but not peripheral blood have no impact on survival of HCMV+ glioblastoma patients. Oncoimmunology. 1-15.
  • 2016. Medicine`s perception of reality - a split picture: critical reflections on apparent anomalies within the biomedical theory of science. Journal of Evaluation In Clinical Practice. 496-501.
  • 2016. Identification of a natural killer cell receptor allele that prolongs survival of cytomegalovirus-positive glioblastoma patients. Cancer Research. 5326-5336.
  • 2016. Den rette måten å vere i verda på. Mogleggjerande vilkår for åtferd, vitskap og naturforvalting. Norsk Filosofisk tidsskrift. 80-92.
  • 2015. Subjective health complaints are not associated with tick bites or antibodies to Borrelia burgdorferi sensu lato in blood donors in western Norway: a cross-sectional study. BMC Public Health. 8 pages.
  • 2015. Peripheral blood monocyte and T-lymphocyte activation levels at diagnosis predict long-term survival in head and neck squamous cell carcinoma patients. Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS). 305-314.
  • 2015. In vitro-stimulated IL-6 monocyte secretion and in vivo peripheral blood T lymphocyte activation uniquely predicted 15-year survival in patients with head and neck squamous cell carcinoma. PLOS ONE.
  • 2014. Seroprevalence of antibodies to tick-borne encephalitis virus and Anaplasma phagocytophilum in healthy adults from western Norway. Scandinavian Journal of Infectious Diseases. 52-56.
  • 2014. Seroprevalence of antibodies to Borrelia burgdorferi sensu lato in healthy adults from western Norway: risk factors and methodological aspects. Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS). 1114-1124.
  • 2014. Can person-free medical knowledge inform person-centered medical practice? European Journal for Person Centered Healthcare. 32-36.
  • 2013. Tick bites in healthy adults from western Norway: Occurrence, risk factors, and outcomes. Ticks and Tick-borne Diseases. 304-310.
  • 2012. Mycobacterium tuberculosis Mcel protein complex initiates rapid induction of transcription of genes involved in substrate trafficking. Genes and Immunity. 496-502.
  • 2012. Fcγ receptors in Norwegian multiple sclerosis patients and healthy controls. Acta Neurologica Scandinavica, Supplementum. 84-89.
  • 2011. The human biology - saturated with experience. Tidsskrift for Den norske legeforening. 683-687.
  • 2011. Supplementation with a Soluble Beta-Glucan Exported from Shiitake Medicinal Mushroom, Lentinus edodes (Berk.) Singer Mycelium: a Crossover, Placebo-Controlled Study in Healthy Elderly. International Journal of Medicinal Mushrooms. 319-326.
  • 2011. Modulation of transcriptional and inflammatory responses in murine macrophages by the mycobacterium tuberculosis mammalian cell entry (Mce) 1 complex. PLOS ONE. 11 pages.
  • 2011. Menneskets biologi-mettet med erfaring. Tidsskrift for Den norske legeforening. 683-687.
  • 2009. The hepatitis C virus enigma. Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS). 427-439.
  • 2009. Cooperation and conflict in host-microbe relations. Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS). 311-322.
  • 2008. Chronic fatigue syndrome defies the mind-body-schism of medicine. New perspectives on a multiple realisable developmental systems disorder. Medicine, Health care and Philosophy. 285-292.
  • 2007. T cells remaining after intensive chemotherapy for acute myelogenous leukemia show a broad cytokine release profile including high levels of interferon-gamma that can be further increased by a novel protein kinase C agonist PEP005. Cancer Immunology and Immunotherapy. 013-925.
  • 2007. Effects of interferon gamma on native human acute myelogenous leukaemia cells. Cancer Immunology and Immunotherapy. 13-24.
  • 2007. B-lymphocytes as targets for therapy in chronic cold agglutinin disease. Cardiovascular & Haematological Disorders-Drug Targets. 219-227.
  • 2006. Primary chronic cold agglutinin disease: a population based clinical study of 86 patients. Studies in Surface Science and Catalysis. 460-466.
  • 2006. Presence of activated T lymphocytes in peripheral blood of head and neck squamous cell carcinoma patients predicts impaired prognosis. Acta Oto-Laryngologica. 1326-1333.
  • 2006. Acute suppression of serum IgM and IgA in tank workers exposed to benzene. Scandinavian Journal of Immunology. 690-698.
  • 2005. High dose methylprednisolone induces FcgammaR1 on granulocytes in MS-patients. Journal of Neuroimmunology. 138-142.
  • 2005. CD34 expression in native human acute myelogenous leukemia blasts: Differences in CD34 membrane molecule expression are associated with different gene expression profiles. Cytometry. 18-27.
  • 2004. The effects of interferon-alpha2a on concentrations of immunoglobulins, complement and lymphocytes in patients with multiple sclerosis. Scandinavian Journal of Immunology. 103-108.
  • 2004. Rituximab for primary chronic cold agglutinin disease: a prospective study of 37 courses of therapy in 27 patients. Blood. 2925-2928.
  • 2004. Population-based hematologic and immunologic reference values for a healthy Ugandan population. Clinical and Laboratory Immunology. 29-34.
  • 2004. Immunoglobulin levels amongst persons with and without human immunodeficiency virus type 1 infection in Uganda and Norway. Scandinavian Journal of Immunology. 203-208.
  • 2004. Characterization of ribosomal P autoantibodies in relation to cell destruction and autoimmune disease. Scandinavian Journal of Immunology. 189-198.
  • 2003. The immune response to pneumococcal polysaccharide vaccine in zinc depleted mice. Scandinavian Journal of Immunology. 76-80.
  • 2003. Performance characteristics of a glycoprotein G based oligopeptide (peptide 55) and two different methods using the complete glycoprotein as assays for detection of anti-HSV-2 antibodies in human sera. Journal of Virological Methods. 21-27.
  • 2003. Performance characteristics of a glycoprotein G based oligopeptide (peptide 55) and two different methods using the complete glycoprotein as assays for detection of anti-HSV-2 antibodies in human sera. Journal of Virological Methods. 21-27.
  • 2003. In vitro culture of human acute lymphoblastic leukemia (ALL) cells in serum-free media; a comparison of native ALL blasts, ALL cell lines and virus-transformed B cell lines. Leukemia Research. 455-464.
  • 2003. Human acute lymphoblastic leukemia (ALL) blasts as accessory cells during T-cell activation: differences between patients in costimulatory capacity affect proliferative responsiveness and cytokine release by activated T cells. Cancer Immunology and Immunotherapy. 215-225.
  • 2003. Changes in Immunoglobulin isotypes and Immunoglobulin G (IgG) subclasses during Highly Active Antiretroviral Therapy. Anti-p24 IgG1 closely parallells the biphasic decline in plasma viremia. Journal of Ascuired Immune Deficiency Syndrome. 358-367.
  • 2002. The evolution and breakdown of the immune system: implications for development of autoimmune diseases. Scandinavian Journal of Immunology. 323-326.
  • 2002. Expression of Fc(epsilon)-receptors by human acute myelogenous leukemia (AML) blasts: studies of high- and low- (CD23) affinity receptor expression and the effects of IgE-mediated receptor ligation on functional AML blast characteristics. Leukemia Research. 515-521.
  • 2002. Effects of cytarabine and various anthracyclins on platelet activation: characterization of in vitro effects and their possible clinical relevance in acute myelogenous leukemia. International Journal of Cancer. 106-114.
  • 2001. Sameining av "dei to kulturane" i medisinen. Vitskapsteori som pedagogisk og terapeutisk verkemiddel. Tidsskrift for Den norske legeforening. 492-494.
  • 2001. Platelet-derived growth factor (PDGF) in human acute myelogenous leukemia: PDGF receptor expression, endogenous PDGF release and responsiveness to exogenous PDGF isoforms by in vitro cultured acute myelogenous leukemia blasts. European Journal of Haematology. 365-376.
  • 2001. Platelet-derived growth factor (PDGF) in human acute myelogenous leukemia: PDGF receptor expression, endogenous PDGF release and responsiveness to exogenous PDGF isoforms by in vitro cultured acute myelogenous leukemia blasts. European Journal of Haematology. 365-376.
  • 2001. Performance characteristics and clinical utility of a hybrid ELISA for detection of ANA. Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS). 217-222.
  • 2001. Measurement of IgM rheumatoid factor by ELISA. Scandinavian Journal of Rheumatology. 366.
  • 2001. Kor stor redaksjonell fridom? Tidsskrift for Den norske legeforening. 858-859.
  • 2001. HIV-1 resistens mot antiretrovirale midler. Tidsskrift for Den norske legeforening. 3421-3424.
  • 2001. Favourable response to therapy with the anti-CD20 monoclonal antibody rituximab in primary chronic cold agglutinin disease. British Journal of Haematology. 79-83.
  • 2001. Favourable Response to Therapy With the Anti-CD20 Monoclonal Antibody Rituximab in Primary Chronic Cold Agglutinin Disease. British Journal of Haematology. 79-83.
  • 2001. Diagnostic and biological significance of anti-p41 IgM antibodies against Borrelia burgdorferi. Scandinavian Journal of Immunology. 416-421.
  • 2001. Det laboratoriemedisinske dilemma. UiB-magasinet : nytt fra Universitetet i Bergen. 22-23.
  • 2001. Clinical utility of diagnostic tests for rheumatoid factor. Scandinavian Journal of Rheumatology. 87-91.
  • 2001. Acute phase haemolysis in chronic cold agglutinin disease. Scandinavian Journal of Immunology. 239-242.
  • 2000. The Cellular Immune system of Patients with Acute Leukemia and Severe Chemotherapy-Induced Leukopenia: Characterization of T Lymphocyte Subsets Responsive to IL-16 and IL-17. Acta Haematologica. 80-91.
  • 2000. Soluble Fas/Apo-1 (CD95) levels during T cell activation in the presence of acute myelogenous leukemia accessory cells; contributions from local release and variations in systemic levels. Cancer Immunology and Immunotherapy. 377-387.
  • 2000. No response to cladribine in five patients with chronic cold agglutinin disease. European Journal of Haematology. 88-90.
  • 2000. LacZ transfected glioma cells in syngeneic rats: Growth pattern and characterization of the host immune response against cells transplanted inside and outside the CNS. International Journal of Cancer. 228-235.
  • 2000. IgG allotypes and subclasses in Norwegian patients with multiple sclerosis. Journal of the Neurological Sciences. 111-115.
  • 2000. Høydosebehandling med autolog stamcellestøtte hos kreftpasienter. Tidsskrift for Den norske legeforening. 1523-1528.
  • 2000. Evaluation of diagnostic tests for antinuclear antibodies in rheumatological practice. Scandinavian Journal of Immunology. 309-315.
  • 2000. Cytokine responsiveness of mitogen-activated T cells derived from acute leukemia patients with chemotherapy-induced leukopenia. Journal of Interferon and Cytokine Research. 947-954.
  • 2000. Anti-cardiolipin autoantibodies and pulmonary embolism. Scandinavian Journal of Rheumatology. 330-333.
  • 2000. Acute myelogenous leukemia blasts as accessory cells during in vitro T lymphocyte activation. Cellular Immunology. 36-50.
  • 1999. Immunologisk utredning ved hypogammaglobulinemi. Tidsskrift for Den norske legeforening. 940-943.
Academic lecture
  • 2012. Spesialisthelsetjenestens utfordringer – nye roller og nye oppgaver for de medisinske laboratoriene.
  • 2012. Fragmentarisk tenkning – hva gikk galt med svineinfluensaen?
  • 2012. Fra menneskets biologi til menneskets biologi.
  • 2012. Betydningen av biologiske relasjoner.
  • 2011. From human BIOLOGY to HUMAN biology.
  • 2003. Global gene expression profiling of human cancers using DNA microarray technology - examples, pitfalls and outlook.
  • 2003. Global analysis of gene expression and regulatory patterns in cancer.
  • 2003. DNA microarray studies of human cancer - pitfalls and outlook.
  • 2002. The effects of interferon-a2a on concentrations of immunoblobulins, complement and lympocytes in patients with multiple sclerosis.
  • 2000. Evaluation of diagnostic tests for antinuclear antibodies in rheumatological practice.
Editorial
  • 2016. Human endogenous retroviruses. Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS). 3-3.
  • 2013. What constitutes competence? That depends on the task. Scandinavian Journal of Primary Health Care. 65-66.
  • 2009. Special issue on Host-microbe relations. APMIS : Acta pathologica, microbiologica et immunologica Scandinavica. Supplementum.
  • 2009. Prising av forskning. Tidsskrift for Den norske legeforening. 616-616.
  • 2009. Prising av forskning. Tidsskrift for Den norske legeforening. 616.
Reader opinion piece
  • 2018. E. Ulvestad svarer. Tidsskrift for Den norske legeforening. 992-993.
  • 2016. På tide med en oppdatert helseforståelse. Morgenbladet.
  • 2016. Persontilpasset medisin – et teknologisk anliggende? Tidsskrift for Den norske legeforening. 1193-1194.
  • 2014. Re: Jakten på det utenomjordiske . Tidsskrift for Den norske legeforening. 2128-2128.
  • 2014. Re: Jakten på det utenomjordiske. Tidsskrift for Den norske legeforening. 1729-1729.
  • 2014. Re: Jakten på det utenomjordiske. Tidsskrift for Den norske legeforening. 2021-2022.
  • 2014. Re: Jakten på det utenomjordiske. Tidsskrift for Den norske legeforening. 1635-1635.
  • 2014. Re: Jakten på det utenomjordiske. Tidsskrift for Den norske legeforening. 1917-1918.
  • 2014. Re: Jakten på det utenomjordiske. Tidsskrift for Den norske legeforening. 1637-1638.
  • 2014. Influensavaksinering av helsepersonell - et moralsk anliggende? Tidsskrift for Den norske legeforening. 278.
  • 2011. Troen som tar liv. På Høyden - nettavis for Universitetet i Bergen.
  • 2010. Meningsløs massevaksinasjon :. Tidsskrift for Den norske legeforening. 2454.
  • 2006. Polemisk sjarlataneri. Morgenbladet.
  • 2006. Forskningsformidling. Bergens Tidende.
Short communication
  • 2012. Vaksinasjonsforskning på tomgang. Tidsskrift for Den norske legeforening. 1730.
  • 2009. Hva er «original» vitenskap? Tidsskrift for Den norske legeforening. 1009.
Book review
  • 2011. Monstrøs utvikling. Bokanmeldelse av Mark S. Blumberg: Freaks of nature. And what they tell us about development and evolution. Tidsskrift for Den norske legeforening. 1333.
  • 2011. Lettfattelig om smittestoffenes økologi. Bokanmeldelse av Bjørn Olsen: Pandemi. Myterna, fakta, hoten. Tidsskrift for Den norske legeforening. 131-131.
  • 2009. Nyttig om evolusjonær medisin. Tidsskrift for Den norske legeforening. 2405-2405.
  • 2008. Meningen med livet - et evolusjonært perspektiv. Tidsskrift for Den norske legeforening.
  • 2005. Organismens gjenkomst. Anmeldelse av Jesper Hoffmeyers bok Biosemiotik. Tidsskrift for Den norske legeforening. 3512.
Academic monograph
  • 2015. Mennesket og mikrobene.
  • 2007. Defending Life. The Nature of Host-Parasite Relations.
Non-fiction book
  • 2001. Diagnostisk immunologi. Norsk Elektronisk Legehåndbok.
Popular scientific article
  • 2012. Livsviktige vaksiner. Hubro. Magasin for Universitetet i Bergen. 60-61.
  • 2009. Mennesket, mikrobene og miljøet - et evolusjonsmedisinsk perspektiv. Naturen. 41-48.
  • 2006. Relasjonar mellom vert og parasitt. Naturen. 9895-103.
  • 2006. Immunsystemet - din naturlege fastlege. Forskning.no.
  • 2006. Evolusjonære overganger, konflikt, samarbeid og sammenbrudd. Naturen. 153-156.
  • 2006. Det instrumentelle dilemma. Nytt Norsk Tidsskrift. 229-240.
Feature article
  • 2019. Jubileum til ettertanke. Tidsskrift for Den norske legeforening. 1-3.
  • 2018. Subjectivity and illness. Tidsskrift for Den norske legeforening. 528-530.
  • 2015. Vaksinasjon – tillit eller tvang? Tidsskrift for Den norske legeforening. 111-111.
  • 2013. Borreliosestriden. Tidsskrift for Den norske legeforening. 2234.
  • 2011. Det udelte mennesket. Aftenposten (morgenutg. : trykt utg.).
  • 2010. Pandemien - bidrag til etterpåklokskap. Tidsskrift for Den norske legeforening. 169-171.
  • 2009. Ved naturvitenskapens grenser. Bergens Tidende.
  • 2009. Retorikk på avveier. Bergens Tidende.
  • 2009. Menneskets gudstro og vitenskap. Bergens Tidende.
  • 2009. Helbredende nytenkning. Aftenposten (morgenutg. : trykt utg.).
  • 2009. Frampeik frå ei faren tid. Tidsskrift for Den norske legeforening. 2622-2624.
  • 2009. Fra modell til virkelighet. Dagens medisin.
  • 2009. Ekspert - men på kva? Tidsskrift for Den norske legeforening. 642-643.
  • 2009. Ekspert - men på kva? Tidsskrift for Den norske legeforening. 642-643.
  • 2007. Overlast og kompleks sykdom - et integrert perspektiv. Tidsskrift for Den norske legeforening. 3228-3231.
  • 2006. Kreft hos barn - gode resultater kan bli enda bedre. Tidsskrift for Den norske legeforening. 926-929.
  • 2006. Intelligent design - brønnpissing eller kjeldevask? Tidsskrift for Den norske legeforening. 184-185.
  • 2005. Nasjonale prøver - oppgjørets time. Forskning.no.
  • 2005. Nasjonale prøver - et uetisk eksperiment? Forskning.no.
  • 2005. Nasjonale prøver - en nasjonal prøvelse. Bergens Tidende.
  • 2005. Nasjonale prøver - en gjøkunge i norsk skole. Forskning.no.
  • 2001. Kamp eller samspel med smittestoffa. Bergens Tidende. 25.
Letter to the editor
  • 2016. Re: Kronisk utmattelsessyndrom/myalgisk encefalopati - sykdomsmekanismer, diagnostikk og behandling. Tidsskrift for Den norske legeforening. 105-105.
  • 2016. Metabolic features of chronic fatigue syndrome revisited. Proceedings of the National Academy of Sciences of the United States of America. E7140-E7141.
  • 2005. Response to: Interleukin-6 and acute ischaemic stroke. Acta Neurologica Scandinavica. 275.
Doctoral dissertation
  • 2004. Primary chronic cold agglutinin disease.
  • 1995. Immune mediated demyelination in multiple sclerosis: A critical role for microglia. Avhandling for dr. med. grad.
Interview
  • 2013. Ny flått-vaksine på vei.
Documentary
  • 2020. Svært viktig at fagmiljøer har fleksibilitet og ressurser til testing av koronavirus .
  • 2020. Nye signaler om koronatester.
Academic chapter/article/Conference paper
  • 2019. "Hemnen" frå systema. 23 pages.
  • 2013. Grunnlag og grenser for klinisk kunnskap. 6 pages.
  • 2011. Kan krigen mot mikrobane vinnast? 8 pages.
  • 2011. Helbredende nytenkning.
Encyclopedia article
  • 2001. Paradoxical cold or warmth. 1128-1129. In:
    • 2001. The Corsini Encyclopedia of Psychology and Behavioral Science.
Abstract
  • 2014. Systems Medicine - holistic and personalized in a humanistic sense? Abstract book: The First International Conference on Systems and Complexity Sciences for Healthcare An Imperative for the 21st Century.
  • 2009. Host-microbe relations. Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS). 309-310.
  • 2006. ERG upregulation in relation to other transcription factors in prostate cancer. NBS-nytt. 72.
Poster
  • 2003. Rituximab for "primary" chronic cold agglutinin disease: a prospective study of 22 courses of therapy in 18 patients.
  • 2001. Clinical utility of diagnostic tests for rheumatoid factor.
Popular scientific book
  • 2009. Rett det som rangt er. Ei samling artiklar om målet på Søre Sunnmøre. Syvde Sogelag.
Academic literature review
  • 2014. Getting personal: Can systems medicine integrate scientific and humanistic conceptions of the patient? 942-952.
  • 2012. Psychoneuroimmunology: The experiential dimension. 21-37.
  • 2007. Global gene expression in classification, pathogenetic understanding and identification of therapeutic targets in Acute Myeloid Leukemia. 344-354.
Popular scientific chapter/article
  • 2009. Ei språkreise. 7-12.
Chapter
  • 2020. Kroppsliggjøring av erfaring og mening - belastende erfaringers innvirkning på menneskets biologi. . 204-234. In:
    • 2020. Sykdommers sosiale røtter. Gyldendal Akademisk.
  • 2019. Tor-Johan Ekeland -- en tenker i en trengselstid. 245-252. In:
    • 2019. Grunnlagsproblemer i vitenskapene om mennesket. Abstrakt forlag.
  • 2019. Hepatittvirus. 340-344. In:
    • 2019. Medisinsk mikrobiologi. Gyldendal Akademisk.
  • 2013. Social learning across the human-microbial interface. 201-216. In:
    • 2013. Social Learning Theory: Phylogenetic Considerations across Animal, Plant, and Microbial Taxa. Nova Science Publishers, Inc..
  • 2009. Molecular microbial diagnostics. 336-364. In:
    • 2009. Molecular Biology and Biotechnology 5th Ed. Springer.
  • 2003. Grunnlag og grenser for klinisk kunnskap. 116-121. In:
    • 2003. Allmennmedisin. Gyldendal Akademisk.
  • 2000. Infeksjonsbeskyttelse. 119-137. In:
    • 2000. Medisinsk mikrobiologi. Gyldendal Akademisk.

More information in national current research information system (CRIStin)